Cosmos Health Inc.
$0.38
▼
-3.85%
2026-04-21 06:10:01
www.cosmoshealthinc.com
NCM: COSM
Explore Cosmos Health Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$20.65 M
Current Price
$0.38
52W High / Low
$1.32 / $0.28
Stock P/E
—
Book Value
$0.73
Dividend Yield
—
ROCE
-53.42%
ROE
-63.82%
Face Value
—
EPS
$-0.77
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Distribution
Employees
149
Beta
4.46
Debt / Equity
91.08
Current Ratio
0.99
Quick Ratio
0.82
Forward P/E
-2.73
Price / Sales
0.19
Enterprise Value
$30.62 M
EV / EBITDA
-2.43
EV / Revenue
0.51
Rating
Strong Buy
Target Price
$4.5
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Synergy CHC Corp. | $0.51 | — | $5.93 M | — | -93.25% | 62.08% | $4 / $0.42 | $-0.73 |
| 2. | Cencora, Inc. | $310.27 | — | $13.74 B | 0.73% | 20.96% | 1.33% | $377.54 / $271 | $9.81 |
| 3. | Henry Schein, Inc. | $78.73 | 24.1 | $9.06 B | — | 9.49% | 8.7% | $89.29 / $61.95 | $28.03 |
| 4. | Empro Group Inc. | $17.36 | — | $144.63 M | — | 39.59% | 66.26% | $18.14 / $2.55 | $1.02 |
| 5. | Accendra Health, Inc. | $3.52 | — | $270.97 M | — | 14.74% | -1.64% | $9.55 / $1.84 | $-6.04 |
| 6. | McKesson Corporation | $837.14 | 24.1 | $102.52 B | 0.38% | 35.58% | -162.92% | $999 / $637 | $-10.55 |
| 7. | Cardinal Health, Inc. | $202.95 | 29.15 | $47.74 B | 0.95% | 16.32% | -52.09% | $233.6 / $129.52 | $-12.22 |
Quarterly Results
Figures shown in M / B
| Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|
| Sales | 17.11 M | 14.75 M | 13.71 M | 14.22 M | 12.41 M |
| Operating Profit | -1.82 M | -2.65 M | -0.83 M | -8.67 M | -2.24 M |
| Net Profit | -5.35 M | -2.83 M | -0.82 M | -9.54 M | -2.18 M |
| EPS in Rs | -0.14 | -0.08 | -0.02 | -0.26 | -0.06 |
Profit & Loss
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Sales | 54.43 M | 53.38 M | 50.35 M | 56.24 M |
| Operating Profit | -15.25 M | -21.83 M | -7.47 M | -4.53 M |
| Net Profit | -16.18 M | -18.54 M | -13.83 M | -7.96 M |
| EPS in Rs | -0.43 | -0.5 | -0.37 | -0.21 |
Balance Sheet
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Total Assets | 54.31 M | 66.01 M | 68.04 M | 49.43 M |
| Total Liabilities | 29.78 M | 29.97 M | 28.38 M | 45.05 M |
| Equity | 24.53 M | 36.04 M | 39.66 M | 4.38 M |
| Current Assets | 25.46 M | 36.61 M | 56.37 M | 39.83 M |
| Current Liabilities | 25.76 M | 24.32 M | 21.75 M | 29.93 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | -7.72 M | -15.64 M | -14.87 M | -7.1 M |
| Investing CF | -0.8 M | -13.76 M | -0.02 M | -0.83 M |
| Financing CF | 5.05 M | 12.69 M | 35.05 M | 7.27 M |
| Free CF | -8.98 M | -24.8 M | -15.25 M | -7.99 M |
| Capex | -1.27 M | -9.17 M | -0.38 M | -0.89 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 1.97% | 6.02% | -10.48% | — |
| Earnings Growth % | 12.73% | -34.07% | -73.71% | — |
| Profit Margin % | -29.73% | -34.74% | -27.47% | -14.16% |
| Operating Margin % | -28.02% | -40.9% | -14.84% | -8.06% |
| Gross Margin % | 7.92% | 8.15% | 11.83% | 14.81% |
| EBITDA Margin % | -25.58% | -31.96% | -17.68% | -6.79% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.